NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.48%
This Quarter Est. Return
1 Year Est. Return
+3.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$615M
AUM Growth
-$141M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$12.1M
2
+$7.61M
3
+$5.77M
4
ON icon
ON Semiconductor
ON
+$4.59M
5
JD icon
JD.com
JD
+$4.02M

Top Sells

1
+$17.6M
2
+$10.3M
3
+$9.9M
4
CRM icon
Salesforce
CRM
+$5.12M
5
XLE icon
Energy Select Sector SPDR Fund
XLE
+$4.3M

Sector Composition

1 Communication Services 30.78%
2 Consumer Discretionary 25.29%
3 Technology 13.22%
4 Financials 12.6%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TAL icon
26
TAL Education Group
TAL
$7.16B
$6.1M 0.99%
228,791
ALXN
27
DELISTED
Alexion Pharmaceuticals
ALXN
$6.08M 0.99%
62,500
ATUS icon
28
Altice USA
ATUS
$1.01B
$5.6M 0.91%
339,042
GILD icon
29
Gilead Sciences
GILD
$152B
$5.44M 0.88%
86,959
BMY icon
30
Bristol-Myers Squibb
BMY
$93.7B
$4.83M 0.79%
93,000
APLS icon
31
Apellis Pharmaceuticals
APLS
$2.62B
$4.71M 0.77%
357,142
DB icon
32
Deutsche Bank
DB
$69.7B
$4.26M 0.69%
533,225
PM icon
33
Philip Morris
PM
$225B
$4.21M 0.68%
63,000
IBB icon
34
iShares Biotechnology ETF
IBB
$6.3B
$4.17M 0.68%
43,200
CRM icon
35
Salesforce
CRM
$249B
$3.85M 0.63%
28,088
-37,362
SAGE
36
DELISTED
Sage Therapeutics
SAGE
$3.11M 0.51%
32,506
VTRS icon
37
Viatris
VTRS
$12.2B
$2.74M 0.45%
100,000
IOVA icon
38
Iovance Biotherapeutics
IOVA
$706M
$2.02M 0.33%
228,442
+103,588
SLB icon
39
SLB Ltd
SLB
$55.3B
$2M 0.33%
55,500
INCY icon
40
Incyte
INCY
$19.9B
$1.97M 0.32%
31,000
HIMX
41
Himax Technologies
HIMX
$1.62B
$1.61M 0.26%
470,000
MNK
42
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.61M 0.26%
102,000
VKTX icon
43
Viking Therapeutics
VKTX
$4.07B
$1.07M 0.17%
+140,000
TEVA icon
44
Teva Pharmaceuticals
TEVA
$23.5B
$817K 0.13%
53,000
FLNT
45
Fluent
FLNT
$59.6M
$701K 0.11%
32,467
XLRN
46
DELISTED
Acceleron Pharma
XLRN
$626K 0.1%
14,369
GS icon
47
Goldman Sachs
GS
$236B
$618K 0.1%
3,700
VIPS icon
48
Vipshop
VIPS
$8.66B
$287K 0.05%
52,644
ARAV
49
DELISTED
Aravive, Inc. Common Stock
ARAV
$144K 0.02%
40,816
DNLI icon
50
Denali Therapeutics
DNLI
$2.25B
– –
-112,273
1
2
3